The Clorox Company
CLX
$117.61
-$0.16-0.14%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.68% | -9.35% | 0.16% | -2.64% | -1.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.68% | -9.35% | 0.16% | -2.64% | -1.98% |
| Cost of Revenue | -5.08% | -8.89% | -3.28% | -7.42% | -6.05% |
| Gross Profit | -6.43% | -9.92% | 4.67% | 3.91% | 3.61% |
| SG&A Expenses | -8.27% | -8.75% | -4.48% | 0.25% | 1.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -26.32% | -50.00% | -81.25% | -70.00% | -54.76% |
| Total Operating Expenses | -6.26% | -8.98% | -4.08% | -5.42% | -4.13% |
| Operating Income | -2.22% | -11.39% | 28.52% | 16.93% | 12.99% |
| Income Before Tax | 52.40% | 84.62% | 170.85% | 161.94% | 312.10% |
| Income Tax Expenses | 20.67% | 16.48% | 139.62% | 116.67% | 179.69% |
| Earnings from Continuing Operations | 64.53% | 117.03% | 182.19% | 181.35% | 403.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -36.36% | 7.69% | -16.67% | -25.00% | 15.38% |
| Net Income | 65.21% | 121.57% | 189.29% | 189.17% | 471.25% |
| EBIT | -2.22% | -11.39% | 28.52% | 16.93% | 12.99% |
| EBITDA | -1.68% | -9.86% | 21.80% | 11.99% | 8.99% |
| EPS Basic | 66.74% | 123.06% | 191.19% | 189.29% | 474.73% |
| Normalized Basic EPS | -3.11% | -11.34% | 34.36% | 20.83% | 17.94% |
| EPS Diluted | 67.12% | 122.84% | 192.31% | 190.05% | 488.64% |
| Normalized Diluted EPS | -3.02% | -11.43% | 34.04% | 20.49% | 17.74% |
| Average Basic Shares Outstanding | -1.08% | -0.72% | -0.52% | -0.20% | 0.10% |
| Average Diluted Shares Outstanding | -1.18% | -0.62% | -0.29% | 0.06% | 0.22% |
| Dividend Per Share | -23.87% | 1.65% | 1.66% | 1.67% | 1.67% |
| Payout Ratio | -0.39% | -0.54% | -0.65% | -0.65% | -0.82% |